首页 > 市场调查报告书 > 製药

眼科药物

市场调查报告书

商品编码

1535660

非处方干眼药水市场 - 按产品类型（防腐剂、不含防腐剂）、类型（品牌、仿製药）、黏度（低、高）、配销通路（线上药房、零售药房） - 全球预测（2024 - 2032）

OTC Dry Eye Drops Market - By Product Type (Preservative, Preservative-free), Type (Branded, Generics), Viscosity (Low, High), Distribution Channel (Online Pharmacies, Retail Pharmacies) - Global Forecast (2024 - 2032)

出版日期: 2024年06月12日 | 出版商:

Global Market Insights Inc. | 英文 195 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2024 年至 2032 年间，非处方干眼药水市场的复合年增长率将达到 7.6%，主要是由于干眼症发病率上升所致。人口老化和萤幕时间延长导致眼部疾病病例增加，从而增加了对非处方药的需求。根据美国眼科学会2022年的研究，近1,600万美国人患有干眼症，而且这种症候群在老年人中更为普遍。

人们对非处方干眼药水的偏好激增，尤其是那些寻求快速缓解眼睛刺激等症状的人，这些症状通常与长时间接触数位萤幕和环境污染物有关。此外，产品创新和技术进步也在扩大市场份额。製造商正在推出具有更高功效、更持久的缓解效果和更少副作用的配方。不含防腐剂和低过敏性选择的出现正在扩大产品的吸引力。消费者对眼睛健康的意识不断增强，加上产品系列多样化，将塑造产业前景。

整个非处方干眼药水市场根据产品类型、类型、黏度、配销通路和地区进行细分。

无防腐剂市场的需求量大，这主要是由于消费者对眼睛健康的认识和敏感度不断提高。眼药水中的防腐剂虽然能有效防止细菌生长，但有时会加剧干燥和刺激，特别是对于眼睛敏感或需要经常使用的人。不含防腐剂的配方提供了更安全的替代方案，降低了额外刺激的风险，并使它们更适合经常使用。个人化和温和的眼部护理解决方案的更广泛趋势将有利于该细分市场的成长。

由于与品牌药物相比，仿製药具有成本效益和可及性，预计到 2032 年将占据显着的市场份额。仿製药产品的功效和安全性与其品牌同类产品相似，但价格较低。随着医疗保健成本的上升和消费者寻求更实惠的治疗选择，仿製药提供了实用的解决方案，同时又不影响品质。此外，自我药疗的趋势不断增长，以及零售和线上通路中仿製药的供应不断增加，也导致其越来越受欢迎。

到 2032 年，由于人们对眼睛健康的认识不断提高、干眼症发病率上升以及医疗保健产品的获取范围扩大，拉丁美洲的非处方干眼药水行业规模将大幅扩张。巴西和墨西哥等国家的经济改善导致可支配收入增加，使更多消费者能够负担得起眼部护理产品。此外，快速的城市化以及由此导致的人口萤幕时间的增加加剧了干眼症状，从而增加了对有效非处方药解决方案的需求。分销网络的增强和国际品牌的进入，使该地区的消费者可以轻鬆获得更广泛的产品，从而促进了该地区市场的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 干眼症盛行率上升
  - 提高意识和自我保健实践
  - 增加萤幕时间和数位装置的使用
  - 产品配方的技术进步
- 产业陷阱与挑战
  - 副作用和过敏反应
  - 替代治疗的可用性
成长潜力分析
监管环境
技术景观
- 核心技术
- 邻近技术
2023 年定价分析
- 按地区
- 按关键人物
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

主要趋势
防腐剂
不含防腐剂

第 6 章：市场估计与预测：按类型，2021 - 2032

主要趋势
品牌化
泛型

第 7 章：市场估计与预测：按黏度分类，2021 - 2032 年

主要趋势
低黏度
高黏度

第 8 章：市场估计与预测：按配销通路划分，2021 - 2032 年

主要趋势
网路药局
零售药局
其他分销管道

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

AbbVie, Inc.
Alcon
Allergan plc
Altaire Pharmaceutical Inc.
Bausch Health Companies Inc.
IDEX CORPORATION
Johnson & Johnson
Medicom Healthcare Pvt Ltd.
Novartis AG
OASIS
Prestige Consumer Healthcare Inc.
Rohto Pharmaceutical Co., Ltd.
Similasan Corporation
Sentiss Pharma Private Limited

简介目录

Product Code: 9823

The OTC dry eye drops market is anticipated to record 7.6% CAGR between 2024 and 2032, primarily driven by the rising incidence of dry eye disease. Aging populations and prolonged screen time is leading to an increase in eye condition cases, bolstering the demand for over-the-counter remedies. As per a study by the American Academy of Ophthalmology in 2022, nearly 16 million Americans suffer from dry eye disease, and this syndrome is found to be more prevalent in the elderly.

There is a surge in preference for OTC dry eye drops, especially among those seeking quick relief from symptoms like eye irritation, often linked to extended digital screen exposure and environmental pollutants. Further, product innovation and technological advancements are also expanding the market share. Manufacturers are introducing formulations with heightened efficacy, longer-lasting relief, and fewer side effects. The advent of preservative-free and hypoallergenic options is broadening the product appeal. The growing consumer awareness regarding eye health, in tandem with availability of diverse product range, will shape the industry outlook.

The overall OTC dry eye drops market is segmented based on product type, type, viscosity, distribution channel, and region.

The preservative-free segment is witnessing high demand, primarily due to increasing consumer awareness and sensitivity regarding eye health. Preservatives in eye drops, while effective at preventing bacterial growth, can sometimes exacerbate dryness and irritation, especially in individuals with sensitive eyes or those requiring frequent use. Preservative-free formulations offer a safer alternative, reducing the risk of additional irritation and making them more suitable for regular use. The broader trend towards personalized and gentle eye care solutions will favor the segment growth.

The generic segment is slated to hold a notable market share by 2032, due to their cost-effectiveness and accessibility compared to branded counterparts. Generic products offer similar efficacy and safety profiles as their branded equivalents but at a lower price point. As healthcare costs rise and consumers seek more affordable treatment options, generics provide a practical solution without compromising on quality. Additionally, the growing trend towards self-medication and the increasing availability of generics in retail and online channels contribute to their rising popularity.

OTC dry eye drops industry size in Latin America will expand at a significant pace through 2032, driven by increasing awareness about eye health, rising incidences of dry eye syndrome, and expanding access to healthcare products. Economic improvements in countries like Brazil and Mexico have led to higher disposable incomes, enabling more consumers to afford eye care products. Furthermore, rapid urbanization and the resulting increase in screen time among the population have exacerbated dry eye symptoms, boosting demand for effective OTC solutions. The enhanced distribution networks and the entry of international brands, making a wider range of products readily available to consumers across the region, are bolstering the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of dry eye syndrome
  - 3.2.1.2 Growing awareness and self-care practices
  - 3.2.1.3 Increased screen time and digital device usage
  - 3.2.1.4 Technological advancements in product formulations
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Side effects and allergic reactions
  - 3.2.2.2 Availability of alternative treatments
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Preservative
5.3 Preservative-free

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Branded
6.3 Generics

Chapter 7 Market Estimates and Forecast, By Viscosity, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Low viscosity
7.3 High viscosity

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Online pharmacies
8.3 Retail pharmacies
8.4 Other distribution channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa